Description of Event or Problem · 0
A ELDERLY MALE PRESENTED TO THE OUTPATIENT INFUSION CENTER TO BE SET UP FOR 5-FU CHEMO THERAPY USING AN ELASTOMERIC GRAVITY FED INFUSION DEVICE. THE CHEMO WAS INTENDED TO INFUSE AT HOME OVER A 46-HOUR PERIOD. AFTER THE PATIENT GOT HOME HE REALIZED THAT THE ENTIRE 250 ML BALLOON OF CHEMO HAD INFUSED OVER A ONE-HOUR PERIOD INSTEAD OF 46-HOURS. HE RETURNED TO THE HOSPITAL. AN ANTIDOTE TO THE CHEMO AGENT WAS INITIATED WITH THE PLAN TO RETURN DAILY OVER A PERIOD OF A WEEK TO RECEIVE THE EACH DOSE OF THE ANTIDOTE, ALONG WITH IV FLUIDS AND DAILY RE-EXAMINATION BY HIS ONCOLOGIST. UPON REVIEW OF THE EVENT, IT WAS DISCOVERED THAT THE ELASTOMERIC DEVICE WAS UNDER TRIAL AT OUR FACILITY. THE COMPANY REP HAD PROVIDED US WITH 6 ELASTOMERIC DEVICES (SOME FOR CHEMO AND SOME FOR ANTIBIOTICS) SO STAFF COULD BECOME FAMILIAR WITH HOW TO FILL THEM. DUE TO INEXPERIENCE, ONE OF THE ANTIBIOTIC DEVICES (PRE-DETERMINED TO INFUSE OVER ONE HOUR) WAS SELECTED FOR USE INSTEAD OF THE CHEMO DEVICE (PRE-DETERMINED TO INFUSE OVER 46-HOURS). WE REQUEST THE MANUFACTURER TO CONSIDER EITHER MAKING THE DIFFERENT DEVICES IN A NEON COLOR, OR TO PRINT IN LARGE BOLD LETTERS WHICH TYPE OF AGENT IS INTENDED FOR WHICH TYPE OF MEDICATION.